Eltrombopag reduces clinically relevant thrombocytopenic events in higher risk MDS and AML

Research output: Contribution to journal › Comment/debate › peer-review

ASJC Scopus subject areas

@article{ecda81a5eb1b4a73a737e94001794740,

title = "Eltrombopag reduces clinically relevant thrombocytopenic events in higher risk MDS and AML",

author = "Aditi Shastri and Verma, \{Amit K.\}",

year = "2018",

month = jan,

doi = "10.1016/S2352-3026(17)30229-6",

language = "English (US)",

volume = "5",

pages = "e6--e7",

journal = "The Lancet Haematology",

issn = "2352-3026",

publisher = "Elsevier Limited",

number = "1",

}

TY - JOUR

T1 - Eltrombopag reduces clinically relevant thrombocytopenic events in higher risk MDS and AML

AU - Shastri, Aditi

AU - Verma, Amit K.

PY - 2018/1

Y1 - 2018/1

UR - https://www.scopus.com/pages/publications/85037733772

UR - https://www.scopus.com/pages/publications/85037733772#tab=citedBy

U2 - 10.1016/S2352-3026(17)30229-6

DO - 10.1016/S2352-3026(17)30229-6

M3 - Comment/debate

C2 - 29241763

AN - SCOPUS:85037733772

SN - 2352-3026

VL - 5

SP - e6-e7

JO - The Lancet Haematology

JF - The Lancet Haematology

IS - 1

ER -